UW–Madison responds to NIH announcement about indirect cost cap
The University of Wisconsin–Madison is one of the world’s leading engines of biomedical research. This proposed change to NIH funding – UW–Madison’s largest source of federal support – will significantly disrupt vital research activity and delay lifesaving discoveries and cures related to cancer, Alzheimer’s disease, diabetes, and much more.